{
    "clinical_study": {
        "@rank": "151155", 
        "brief_summary": {
            "textblock": "The main purpose of this study is to investigate the association between VEGF gene\n      polymorphism and the response to intravitreal drugs in neovascular age-related macular\n      degeneration. This is a retrospective review of patients treated between 2008 and 2012 at\n      the Institute of Vision, in Belo Horizonte, Brazil."
        }, 
        "brief_title": "VEGF Gene Association With Response to Neovascular Age-related Macular Degeneration With Anti-VEGF Agents", 
        "condition": "Macular Degeneration", 
        "condition_browse": {
            "mesh_term": [
                "Macular Degeneration", 
                "Wet Macular Degeneration"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Diagnosis of neovascular age-related macular degeneration\n\n          -  Visual acuity better than 20/400\n\n          -  Loading dose with three intravitreal injections of anti-VEGF agents, administred one\n             per month over three months\n\n          -  Follow-up period of at least six months\n\n        Exclusion Criteria:\n\n          -  Choroidal neovascularization secondary to any other cause than age-related macular\n             degeneration\n\n          -  Eyes with polypoidal choroidal vasculopathy\n\n          -  Eyes previously submitted to posterior vitrectomy\n\n          -  Other diseases that could affect visual acuity"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "50 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Eye clinic in Belo Horizonte, Brazil"
            }
        }, 
        "enrollment": {
            "#text": "74", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 31, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01655589", 
            "org_study_id": "IV-01"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "July 31, 2012", 
        "location": {
            "contact": {
                "email": "andre@ivisao.com", 
                "last_name": "Andre B Ferreira", 
                "phone": "55 31 32743355"
            }, 
            "facility": {
                "address": {
                    "city": "Belo Horizonte", 
                    "country": "Brazil", 
                    "state": "MG", 
                    "zip": "30150270"
                }, 
                "name": "Institute of Vision"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Brazil"
        }, 
        "number_of_groups": "1", 
        "official_title": "VEGF Gene Polymorphism and Response to Intravitreal Anti-VEGF Agents in Neovascular Age-related Macular Degeneration", 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Brazil: National Committee of Ethics in Research"
        }, 
        "phase": "N/A", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01655589"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Institute of Vision, Brasil", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Institute of Vision, Brasil", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2008", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Retrospective", 
        "study_type": "Observational", 
        "verification_date": "July 2012"
    }
}